CDK2 and lung adenocarcinoma: Although CDK4/6 might compensate for CDK2 in regulating cell cycle progression [48], our data revealed that CDK4/6 is not crucial for mitosis‐related mitochondrial fragmentation in lung adenocarcinoma cell lines.